18P NEK1 is a novel cancer target driving tumor growth through altered immune signaling
Ruiz-Pérez, M.V., Gaspar, I., Fekete, I., Szántai-Kis, C., Connolly, S., Elek, B., Djurec, M., Hegedüs, C., Taisz, I., Veres, D.
Published in ESMO open (01.02.2024)
Published in ESMO open (01.02.2024)
Get full text
Journal Article